Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now full pipeline small index

Hepatitis B， Chronic: full-pipeline trial registry

2 of 7 indexed Hepatitis B， Chronic trials are currently recruiting.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

7 US clinical trials · 2 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Hepatitis B， Chronic: 7 US clinical trials tracked, 2 recruiting.

Hepatitis B， Chronic is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is GlaxoSmithKline, running 2 of these trials.

Enrollment posture brief

Registry condition hepatitis-b-chronic

OPEN 2 | RECR 29% | LATE 3 | EARLY 2 | RANK #2497 | SPON 2

Volume-matched condition peers

Nearest open-share peer: Acromegaly (29% recruiting · 14 trials)

ACL Tear71.4%ACL57.1%Acute Myelogenous Leukemia42.9%Hepatitis B， Chronic (this)29%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Hepatitis B， Chronic

Hepatitis B， Chronic lists 2 open slots (29% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hepatitis B， Chronic on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hepatitis B， Chronic is recruiting below its size-band peers.

    2 of 7 indexed trials (28.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Hepatitis B， Chronic research.

    GlaxoSmithKline accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Hepatitis B， Chronic enrolment sits around 550 participants.

    Median target enrolment is 550 among the 7 trials that report a genuine target (sentinel values excluded). 1 of those (14.3%) plan for fewer than 100 participants.

  4. Hepatitis B， Chronic research is mostly interventional.

    5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21Phase 33

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 3

Top Sponsors

GlaxoSmithKline 2 trials
Hologic 1 trials
Precision BioSciences 1 trials
Vir Biotechnology 1 trials
University of Maryland, Baltimore 1 trials
Bristol-Myers Squibb 1 trials

Named interventions

Most-linked intervention names on Hepatitis B， Chronic records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Bepirovirsen Drug
2 trials
Placebo Other
2 trials
Adefovir Drug
1 trials
Entecavir Drug
1 trials
Tenofovir Drug
1 trials
PEG-IFNα Drug
1 trials
PBGENE-HBV Biological
1 trials
VIR-3434 Drug
1 trials

US sites by state

Facility locations filed on Hepatitis B， Chronic trials. A trial with sites in several states counts in each.

Maryland 5 trials
Florida 4 trials
California 4 trials
Virginia 2 trials
Massachusetts 2 trials
Connecticut 2 trials
Colorado 2 trials
Arizona 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Hepatitis B， Chronic page

7 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Hepatitis B， Chronic trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • GlaxoSmithKline sponsors the most Hepatitis B， Chronic trials on record, review their full trial history before evaluating a specific study. See GlaxoSmithKline's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hepatitis B， Chronic condition card totals 7 registered trials; most-linked intervention Bepirovirsen; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.